On July 19th, 2024, Sinopharm (01099.HK) suffered a shareholding reduction of 1.3377 million shares from JPMorgan Chase & Co. at an average price of HKD 18.8408 per share, involving approximately HKD 25.2025 million, according to the latest equity disclosure data from the Hong Kong Stock Exchange.
After the reduction, JPMorgan Chase & Co.'s latest number of shares held is 93.9033 million shares, and the shareholding ratio has decreased from 7.09% to 6.99%.
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240725/0-82b7dfe130dd13d743cc4094ffc391ce-0-b9ee5e846a45143883fe421fc66951ee.png/big)